Globus Medical Debt to Equity Ratio 2010-2018 | GMED
Current and historical debt to equity ratio values for Globus Medical (GMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Globus Medical debt/equity for the three months ending September 30, 2018 was 0.00.
Globus Medical Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2018-09-30 | $0.00B | $1.14B | 0.00 |
2018-06-30 | $0.00B | $1.10B | 0.00 |
2018-03-31 | $0.00B | $1.03B | 0.00 |
2017-12-31 | $0.00B | $0.97B | 0.00 |
2017-09-30 | $0.00B | $0.94B | 0.00 |
2017-06-30 | $0.00B | $0.91B | 0.00 |
2017-03-31 | $0.00B | $0.87B | 0.00 |
2016-12-31 | $0.00B | $0.83B | 0.00 |
2016-09-30 | $0.00B | $0.81B | 0.00 |
2016-06-30 | $0.00B | $0.78B | 0.00 |
2016-03-31 | $0.00B | $0.75B | 0.00 |
2015-12-31 | $0.00B | $0.72B | 0.00 |
2015-09-30 | $0.00B | $0.67B | 0.00 |
2015-06-30 | $0.00B | $0.64B | 0.00 |
2015-03-31 | $0.00B | $0.61B | 0.00 |
2014-12-31 | $0.00B | $0.59B | 0.00 |
2014-09-30 | $0.00B | $0.55B | 0.00 |
2014-06-30 | $0.00B | $0.53B | 0.00 |
2014-03-31 | $0.00B | $0.50B | 0.00 |
2013-12-31 | $0.00B | $0.47B | 0.00 |
2013-09-30 | $0.00B | $0.45B | 0.00 |
2013-06-30 | $0.00B | $0.42B | 0.00 |
2013-03-31 | $0.00B | $0.41B | 0.00 |
2012-12-31 | $0.00B | $0.39B | 0.00 |
2012-09-30 | $0.00B | $0.36B | 0.00 |
2012-06-30 | $0.00B | $0.32B | 0.00 |
2012-03-31 | $0.00B | $0.30B | 0.00 |
2011-12-31 | $0.00B | $0.28B | 0.00 |
2011-09-30 | $0.00B | $0.00B | 0.00 |
2011-06-30 | $0.00B | $0.00B | 0.00 |
2011-03-31 | $0.00B | $0.00B | 0.00 |
2010-12-31 | $0.00B | $0.23B | 0.00 |
2009-12-31 | $0.00B | $0.00B | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $4.688B | $0.636B |
Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $101.538B | 22.68 |
Intuitive Surgical (ISRG) | United States | $62.929B | 59.23 |
Edwards Lifesciences (EW) | United States | $36.708B | 37.59 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $24.505B | 16.57 |
IDEXX Laboratories (IDXX) | United States | $18.185B | 49.52 |
ABIOMED (ABMD) | United States | $16.332B | 107.81 |
Hologic (HOLX) | United States | $13.523B | 20.45 |
Teleflex (TFX) | United States | $13.173B | 29.90 |
DexCom (DXCM) | United States | $12.930B | 0.00 |
Varian Medical Systems (VAR) | United States | $12.041B | 30.08 |
STERIS (STE) | United Kingdom | $10.392B | 26.71 |
Masimo (MASI) | United States | $6.825B | 44.26 |
Penumbra (PEN) | United States | $5.141B | 310.42 |
LivaNova (LIVN) | United Kingdom | $4.861B | 31.20 |
Integra LifeSciences Holdings (IART) | United States | $4.423B | 21.55 |
Wright Medical Group (WMGI) | Netherlands | $3.941B | 0.00 |
Cantel Medical (CMD) | United States | $3.599B | 35.50 |
Inogen (INGN) | United States | $3.000B | 64.75 |
Tandem Diabetes Care (TNDM) | United States | $2.811B | 0.00 |
Integer Holdings (ITGR) | United States | $2.761B | 23.10 |
Glaukos (GKOS) | United States | $2.420B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $2.365B | 21.31 |
OPKO Health (OPK) | United States | $1.612B | 0.00 |
Nevro (NVRO) | United States | $1.461B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $1.358B | 216.18 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $1.244B | 35.93 |
Accelerate Diagnostics (AXDX) | United States | $1.166B | 0.00 |
Luminex (LMNX) | United States | $1.161B | 53.14 |
CryoLife (CRY) | United States | $1.098B | 118.84 |
Pacific Biosciences Of California (PACB) | United States | $1.088B | 0.00 |
Intersect ENT (XENT) | United States | $1.039B | 0.00 |
Natus Medical (BABY) | United States | $0.943B | 19.67 |
Mesa Laboratories (MLAB) | United States | $0.900B | 36.80 |
AngioDynamics (ANGO) | United States | $0.871B | 28.24 |
ViewRay (VRAY) | United States | $0.791B | 0.00 |
Veracyte (VCYT) | United States | $0.771B | 0.00 |
AxoGen (AXGN) | United States | $0.677B | 0.00 |
TransEnterix (TRXC) | United States | $0.653B | 0.00 |
Quotient (QTNT) | Switzerland | $0.640B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.488B | 0.00 |
Si-Bone (SIBN) | United States | $0.466B | 0.00 |
Oxford Immunotec Global (OXFD) | United Kingdom | $0.457B | 0.00 |
Accuray (ARAY) | United States | $0.454B | 0.00 |
Fluidigm (FLDM) | United States | $0.424B | 0.00 |
GenMark Diagnostics (GNMK) | United States | $0.377B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.344B | 0.00 |
SeaSpine Holdings (SPNE) | United States | $0.324B | 0.00 |
Neuronetics (STIM) | United States | $0.310B | 0.00 |
Sientra (SIEN) | United States | $0.304B | 0.00 |
IRadimed (IRMD) | United States | $0.292B | 62.14 |
RTI Surgical (RTIX) | United States | $0.291B | 46.70 |
Corindus Vascular Robotics (CVRS) | United States | $0.251B | 0.00 |
Nuvectra (NVTR) | United States | $0.250B | 0.00 |
CRH Medical (CRHM) | Canada | $0.234B | 40.63 |
Helius Medical Technologies (HSDT) | United States | $0.173B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.163B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.126B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.120B | 0.00 |
Ra Medical Systems (RMED) | United States | $0.093B | 0.00 |
ConforMIS (CFMS) | United States | $0.089B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.087B | 0.00 |
Titan Medical (TMDI) | Canada | $0.083B | 0.00 |
EDAP TMS (EDAP) | France | $0.081B | 0.00 |
Apollo Endosurgery (APEN) | United States | $0.081B | 0.00 |
HTG Molecular Diagnostics (HTGM) | United States | $0.068B | 0.00 |
Alphatec Holdings (ATEC) | United States | $0.061B | 0.00 |
Second Sight Medical Products (EYES) | United States | $0.057B | 0.00 |
Vermillion (VRML) | United States | $0.054B | 0.00 |
OBALON THERPTCS (OBLN) | United States | $0.050B | 0.00 |
Electromed (ELMD) | United States | $0.047B | 24.13 |
Xtant Medical Holdings (XTNT) | United States | $0.045B | 0.00 |
Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
Restoration Robotics (HAIR) | United States | $0.034B | 0.00 |
Viveve Medical (VIVE) | United States | $0.033B | 0.00 |
Navidea Biopharmaceuticals (NAVB) | United States | $0.027B | 0.00 |
PAVmed (PAVM) | United States | $0.026B | 0.00 |
Lianluo Smart (LLIT) | China | $0.025B | 0.00 |
DarioHealth (DRIO) | Israel | $0.023B | 0.00 |
ReWalk Robotics (RWLK) | Israel | $0.022B | 0.00 |
Neovasc (NVCN) | Canada | $0.019B | 0.00 |
Dynatronics (DYNT) | United States | $0.018B | 0.00 |
Bioanalytical Systems (BASI) | United States | $0.015B | 47.67 |
American Shared Hospital Services (AMS) | United States | $0.015B | 11.13 |
Nanovibronix (NAOV) | United States | $0.012B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.012B | 0.00 |
Avinger (AVGR) | United States | $0.011B | 0.00 |
Presbia (LENS) | Ireland | $0.009B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.009B | 0.00 |
Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
InspireMD (NSPR) | Israel | $0.008B | 0.00 |
Micron Solutions (MICR) | United States | $0.007B | 0.00 |
Sunshine Heart Inc (CHFS) | United States | $0.006B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
Check-Cap (CHEK) | Israel | $0.000B | 0.00 |